NKTR – Nektar Therapeutics
Nektar TherapeuticsNKTR
$25.76Name : Nektar Therapeutics
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $319,601,760.00
EPSttm : -9.45
Nektar Therapeutics
$25.76
13.21%$3.92Float Short %
4.98
Margin Of Safety %
Put/Call OI Ratio
0.48
EPS Next Q Diff
-2.34
EPS Last/This Y
-2.49
EPS This/Next Y
0.53
Price
25.85
Target Price
90.67
Analyst Recom
1.75
Performance Q
126.62
Relative Volume
3.52
Beta
0.91
Ticker: NKTR
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-06-02 | NKTR | 0.7963 | 0.11 | 0.10 | 50478 |
| 2025-06-03 | NKTR | 0.7499 | 0.11 | 0.07 | 51762 |
| 2025-06-04 | NKTR | 0.7398 | 0.11 | 0.38 | 52102 |
| 2025-06-05 | NKTR | 0.6744 | 0.12 | 0.08 | 52251 |
| 2025-06-06 | NKTR | 0.676 | 0.12 | 0.39 | 52645 |
| 2025-06-09 | NKTR | 8.8 | 0.12 | 0.57 | 53548 |
| 2025-06-10 | NKTR | 11.36 | 0.12 | 0.18 | 53511 |
| 2025-06-11 | NKTR | 9.48 | 0.12 | 0.15 | 53587 |
| 2025-06-12 | NKTR | 8.75 | 0.11 | 2.51 | 78803 |
| 2025-06-13 | NKTR | 8.54 | 0.13 | 2.73 | 54252 |
| 2025-06-16 | NKTR | 9.26 | 0.15 | 0.37 | 55626 |
| 2025-06-17 | NKTR | 8.73 | 0.16 | 0.38 | 59584 |
| 2025-06-18 | NKTR | 8.6 | 0.17 | 0.11 | 61238 |
| 2025-06-20 | NKTR | 8.52 | 0.20 | 0.67 | 65307 |
| 2025-06-23 | NKTR | 9.54 | 0.18 | 2.91 | 56982 |
| 2025-06-24 | NKTR | 24.76 | 0.20 | 0.87 | 58617 |
| 2025-06-25 | NKTR | 29.09 | 0.37 | 1.05 | 64707 |
| 2025-06-26 | NKTR | 29.67 | 0.44 | 0.76 | 67907 |
| 2025-06-27 | NKTR | 25.76 | 0.48 | 0.63 | 73183 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-06-02 | NKTR | 0.79 | 1.1 | - | -0.77 |
| 2025-06-03 | NKTR | 0.75 | 1.1 | - | -0.77 |
| 2025-06-04 | NKTR | 0.75 | 1.1 | - | -0.77 |
| 2025-06-05 | NKTR | 0.67 | 1.1 | - | -0.77 |
| 2025-06-06 | NKTR | 0.68 | 1.1 | - | -0.75 |
| 2025-06-09 | NKTR | 8.79 | 0.2 | - | -0.75 |
| 2025-06-10 | NKTR | 11.38 | 0.2 | - | -11.19 |
| 2025-06-11 | NKTR | 9.53 | 0.2 | - | -11.19 |
| 2025-06-12 | NKTR | 8.76 | 0.2 | - | -11.19 |
| 2025-06-13 | NKTR | 8.56 | 0.2 | - | -11.19 |
| 2025-06-16 | NKTR | 9.26 | 0.7 | - | -11.19 |
| 2025-06-17 | NKTR | 8.73 | 0.7 | - | -11.19 |
| 2025-06-18 | NKTR | 8.61 | 0.7 | - | -11.19 |
| 2025-06-20 | NKTR | 8.51 | 0.7 | - | -11.19 |
| 2025-06-23 | NKTR | 9.52 | 0.7 | - | -11.19 |
| 2025-06-24 | NKTR | 24.41 | 0.7 | - | -11.19 |
| 2025-06-25 | NKTR | 29.05 | 0.7 | - | -11.19 |
| 2025-06-26 | NKTR | 29.67 | 0.7 | - | -11.19 |
| 2025-06-27 | NKTR | 25.85 | 0.7 | - | -11.19 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-06-02 | NKTR | -4.60 | -6.75 | 5.94 |
| 2025-06-03 | NKTR | -4.60 | -6.75 | 5.94 |
| 2025-06-04 | NKTR | -4.60 | -6.75 | 5.94 |
| 2025-06-05 | NKTR | -4.60 | -6.75 | 5.94 |
| 2025-06-06 | NKTR | -4.60 | -6.75 | 5.94 |
| 2025-06-09 | NKTR | -4.60 | -6.73 | 5.94 |
| 2025-06-10 | NKTR | -41.97 | -6.73 | 5.94 |
| 2025-06-11 | NKTR | -41.97 | -6.73 | 6.30 |
| 2025-06-12 | NKTR | -41.97 | -6.73 | 6.30 |
| 2025-06-13 | NKTR | -41.97 | -6.73 | 6.30 |
| 2025-06-16 | NKTR | -41.97 | 0 | 6.30 |
| 2025-06-18 | NKTR | -41.97 | 0 | 6.30 |
| 2025-06-20 | NKTR | -29.91 | 0 | 6.30 |
| 2025-06-23 | NKTR | -23.78 | 0 | 6.30 |
| 2025-06-24 | NKTR | -23.78 | 0 | 6.30 |
| 2025-06-25 | NKTR | -23.78 | 0 | 6.30 |
| 2025-06-26 | NKTR | -23.78 | 0 | 4.98 |
| 2025-06-27 | NKTR | -16.66 | 0 | 4.98 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.24
Avg. EPS Est. Current Quarter
-2.79
Avg. EPS Est. Next Quarter
-2.58
Insider Transactions
-16.66
Institutional Transactions
Beta
0.91
Average Sales Estimate Current Quarter
9
Average Sales Estimate Next Quarter
9
Fair Value
Quality Score
31
Growth Score
33
Sentiment Score
98
Actual DrawDown %
46
Max Drawdown 5-Year %
Target Price
90.67
P/E
Forward P/E
PEG
P/S
3.66
P/B
23.26
P/Free Cash Flow
EPS
-9.53
Average EPS Est. Cur. Y
-11.19
EPS Next Y. (Est.)
-10.66
Target Price Estimates Raised
3
Target Price Estimates Lowered
Profit Margin
-152.49
Relative Volume
3.52
Return on Equity vs Sector %
-992.3
Return on Equity vs Industry %
-974.5
EPS 1 7Days Diff
EPS 1 30Days Diff
0.29
EBIT Estimation
Nektar TherapeuticsSector: Healthcare
Industry: Biotechnology
Employees: 61
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally. It develops NKTR-358, a regulatory T (Treg) cell stimulator designed to address the imbalance in the immune system underlying autoimmune disorders and chronic inflammatory conditions; PEG-CSF1, a polyethylene glycol (PEG) modified hematopoietic colony stimulating factor protein that is engineered to selectively modulate resolution processes of inflammation and has applications in a number of therapeutic indications, including acute and chronic inflammation; Tumor necrosis factor (TNF) receptor type II (TNFR2) agonist asset is a bivalent antibody molecule used to selectively stimulate TNFR2 receptor activity, without modulation of the TNFR1 signaling; and NKTR-255, an IL-15 receptor agonist designed to boost the immune system's natural ability to fight cancer. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. The company was incorporated in 1990 and is headquartered in San Francisco, California.
stock quote shares NKTR – Nektar Therapeutics Stock Price stock today
news today NKTR – Nektar Therapeutics stock forecast ,stock prediction 2023 2024 2025
marketwatch NKTR – Nektar Therapeutics yahoo finance google finance
stock history NKTR – Nektar Therapeutics invest stock market
stock prices NKTR premarket after hours
ticker NKTR fair value insiders trading